搜索结果131-140 的 866 / anti-TNF drugs

  1. 神经科- Mayo Clinic 新闻 - 妙佑医疗国际

    六月2024. Clot-busting medication helps retiree return to the open road after a stroke June 28, 2024, 04:00 p.m. CDT · Biology-based criteria for diagnosis, ...

  2. 神经科- 临床试验- 妙佑医疗国际

    ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

  3. 神经科- 临床试验- 妙佑医疗国际

    ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

  4. 神经科- 临床试验- 妙佑医疗国际

    ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

  5. 神经科- 临床试验- 妙佑医疗国际

    The purpose of this study is to evaluate the effect of immunotherapy drugs (ipilimumab and nivolumab) in treating patients with glioblastoma that has come back ...

  6. 神经科- 临床试验- 妙佑医疗国际

    ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

  7. 神经科- 临床试验- 妙佑医疗国际

    The purpose of this study is to evaluate the effect of immunotherapy drugs (ipilimumab and nivolumab) in treating patients with glioblastoma that has come back ...

  8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The first part of the study includes the first two phases of therapy: Induction and Consolidation. This part will collect information on the leukemia, as well ...

  9. 女性化激素治疗- 在 Mayo Clinic 治疗 - 妙佑医疗国际

    Specialists at Mayo Clinic are committed to providing the latest and most comprehensive treatment options for transgender, gender diverse and intersex people, ...

  10. 神经科- 临床试验- 妙佑医疗国际

    To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the latest revised criteria in 2015 by ...